TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Swedish Biomedical Consulting AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
21
|
173
|
116 |
Financial expenses |
0
|
33
|
0 |
Earnings before taxes |
202
|
72
|
55 |
EBITDA |
-33
|
104
|
55 |
Total assets |
481
|
291
|
247 |
Current assets |
481
|
291
|
247 |
Current liabilities |
220
|
156
|
174 |
Equity capital |
261
|
136
|
73 |
- share capital |
34
|
33
|
36 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
54.3%
|
46.7%
|
29.6% |
Turnover per employee |
21
|
173
|
116 |
Profit as a percentage of turnover |
961.9%
|
41.6%
|
47.4% |
Return on assets (ROA) |
42.0%
|
36.1%
|
22.3% |
Current ratio |
218.6%
|
186.5%
|
142.0% |
Return on equity (ROE) |
77.4%
|
52.9%
|
75.3% |
Change turnover |
-152
|
66
|
116 |
Change turnover % |
-88%
|
62% | |
Chg. No. of employees |
0
![]() |
0
|
1 |
Chg. No. of employees % |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.